Publication: Short report: No evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate
Issued Date
2005-08-01
Resource Type
ISSN
00029637
Other identifier(s)
2-s2.0-24644463768
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
American Journal of Tropical Medicine and Hygiene. Vol.73, No.2 (2005), 267-268
Suggested Citation
Ravindra K. Gupta, Michele Van Vugt, Lucy Paiphun, Thra Slight, Sornchai Looareesuwan, Nicholas J. White, François Nosten Short report: No evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate. American Journal of Tropical Medicine and Hygiene. Vol.73, No.2 (2005), 267-268. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/16566
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Short report: No evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate
Other Contributor(s)
Abstract
Combinations are set to become the mainstay in treatment and prophylaxis of malaria due to Plasmodium falciparum. Various antimalarials have been implicated in cardiotoxicity via prolongation of the QTc interval. Atovaquone-proguanil is an effective and increasingly popular antimalarial choice when used alone or with artesunate in areas of drug resistance. We report the results of an investigation carried out on the Thai-Burmese border in 42 patients randomized to receive either atovaquone-proguanil or atovaquone-proguanil-artesunate for three days. Electrocardiographic recordings were made at baseline and one hour after each dose. There was no statistically significant change in QTc interval between baseline and any subsequent readings in either treatment group or the cohort as a whole. We conclude that atovaquone-proguanil shows no evidence of cardiotoxicity either alone or when combined with artesunate. Copyright © 2005 by The American Society of Tropical Medicine and Hygiene.